Maurizio C Capogrossi

Glycated fibroblast growth factor-2 is quickly produced in vitro upon low-millimolar glucose treatment and detected in vivo in diabetic mice.

Antonio Facchiano, Vincenzo Fogliano, Francesco Facchiano, 2006, Molecular endocrinology.

The role of nuclear endothelial nitric oxide synthase in the endothelial and prostate microenvironments

Antonella Farsetti, Alfredo Pontecorvi, M. Capogrossi, 2011, Hormone molecular biology and clinical investigation.

microRNAs as peripheral blood biomarkers of cardiovascular disease.

Fabio Martelli, M. Capogrossi, F. Martelli, 2011, Vascular pharmacology.

Smad-Interacting Protein-1 and MicroRNA 200 Family Define a Nitric Oxide-Dependent Molecular Circuitry Involved in Embryonic Stem Cell Mesendoderm Differentiation

Jessica Rosati, Antonella Farsetti, M. Capogrossi, 2011, Arteriosclerosis, thrombosis, and vascular biology.

Enhanced Arteriogenesis and Wound Repair in Dystrophin-Deficient mdx Mice

Fabio Martelli, M. Capogrossi, F. Martelli, 2004, Circulation.

Regenerative therapy in peripheral artery disease.

Giulio Pompilio, M. Capogrossi, P. Biglioli, 2009, Cardiovascular therapeutics.

Platelet-derived growth factor inhibits basic fibroblast growth factor angiogenic properties in vitro and in vivo through its alpha receptor.

Antonio Facchiano, Alessandro Lentini, Claudia Giampietri, 2002, Blood.

Cardiac stem cells fail with aging: a new mechanism for the age-dependent decline in cardiac function.

M. Capogrossi, Maurizio C Capogrossi, 2004, Circulation research.

Vascular endothelial growth factor modulates skeletal myoblast function.

M. Capogrossi, P. Turrini, A. Mangoni, 2003, The American journal of pathology.

Identification of a Novel Domain of Fibroblast Growth Factor 2 Controlling Its Angiogenic Properties*

Antonio Facchiano, Angelo M Facchiano, Francesco Facchiano, 2003, The Journal of Biological Chemistry.